(Q36526954)

14 August 2017

1 reference

title

CD4 regulatory T cells in human cancer pathogenesis (English)

1 reference

14 August 2017

Keith L Knutson

1

1 reference

14 August 2017

Mary L Disis

series ordinal

2

1 reference

14 August 2017

Lupe G Salazar

series ordinal

3

1 reference

14 August 2017

publication date

4 July 2006

1 reference

Cancer Immunology, Immunotherapy

14 August 2017

published in

1 reference

14 August 2017

volume

56

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

271-285

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-006-0194-y

14 August 2017

exact match

0 references

cites work

Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0194-Y

CCR8 is expressed by antigen-elicited, IL-10-producing CD4+CD25+ T cells, which regulate Th2-mediated granuloma formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0194-Y

Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0194-Y

TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0194-Y

Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0194-Y

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0194-Y

IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0194-Y

Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-006-0194-Y

10.1007/S00262-006-0194-Y

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference